Evotec stock: JPMorgan disclosure adds focus before results
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
JPMorgan Chase & Co. disclosed a changed combined position in Evotec ahead of the company's first nine-month 2026 results and business update on November 5. The disclosure, published on October 29, shows JPMorgan's combined position at 3.86 percent of voting rights attached to shares and 2.69 percent through instruments.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.